• Home
  • Mutual Funds
  • Bajaj Finserv Healthcare Fund Growth

Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹500 & Lump. ₹500

AUM (Fund size)

₹315 Cr

Lock In Period

N/A

Expense Ratio

2.39

Benchmark

BSE Healthcare Total Return

Exit Load

For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP) and Systematic Transfer Plan (STP), exit load will be as follows:If units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV.If units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable.

Summary

Latest details for Bajaj Finserv Healthcare Fund Growth include a ₹9.323 NAV as of Apr 09,2026 and returns since inception of --%. Minimum investments start at SIP ₹500. The Bajaj Finserv Healthcare Fund Growth AUM is ₹315 Cr, with a lock-in of N/A years, expense ratio of 2.39%, and benchmark BSE Healthcare Total Return. Exit load is - For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP) and Systematic Transfer Plan (STP), exit load will be as follows:If units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV.If units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable.. In the growth review for 1M Month/Year, the fund recorded -1.57% returns, against a category average of 2.27% and a category best of 19.98%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-1.572.2719.98
6M-4.492.9465.52
1Y4.3810.19235.44
3Y0.0015.88262.04

Portfolio Analysis

  • Equity: 97.52%
  • Debt: 2.48%
  • Others
As on: 2026-02-28
View allocation % by

1. Divi's Laboratories Limited9.21%
2. Sun Pharmaceutical Industries Limited8.40%
3. Piramal Pharma Limited6.21%
4. Aurobindo Pharma Limited5.93%
5. Torrent Pharmaceuticals Limited5.46%
6. Emcure Pharmaceuticals Limited3.79%
7. Rubicon Research Limited3.70%
8. Neuland Laboratories Limited3.40%
9. Lupin Limited2.65%
10. IPCA Laboratories Limited2.45%
11. GlaxoSmithKline Pharmaceuticals Limited1.94%
12. Glenmark Pharmaceuticals Limited1.88%
13. Abbott India Limited1.46%
14. Biocon Limited1.42%
15. MedPlus Health Services Limited1.39%
16. Eris Lifesciences Limited1.08%
17. Cipla Limited1.02%
18. Jubilant Pharmova Limited0.96%
19. AstraZeneca Pharma India Limited0.92%
20. Alembic Pharmaceuticals Limited0.90%

1. Apollo Hospitals Enterprise Limited6.80%
2. Max Healthcare Institute Limited4.40%
3. Fortis Healthcare Limited3.60%
4. Vijaya Diagnostic Centre Limited1.97%
5. Dr. Lal Path Labs Limited1.57%
6. Krishna Institute Of Medical Sciences Limited1.18%

1. Godrej Consumer Products Limited1.93%
2. Hindustan Uever Limited1.16%
3. Emami Limited0.95%

1. Zydus Wellness Limited2.00%

1. Navin Fluorine International Limited1.99%

1. Sanofi Consumer Healthcare India Limited1.98%

1. Shaily Engineering Plastics Limited1.54%

1. Medi Assist Healthcare Services Limited1.18%

1. Tata Consumer Products Limited1.09%

About Fund

Bajaj Finserv Healthcare Fund Growth managed by Bajaj Finserv Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹315 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.39. Under the expert guidance of Nimesh Chandan ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
This FundAxis India Manufacturing Fund Growth05175.61 CR1.83
This FundKotak Active Momentum Fund Growth01338.83 CR2.13
This FundBajaj Finserv Healthcare Fund Growth0314.74 CR2.39
This FundICICI Prudential PSU Equity Fund Growth02021.84 CR2.08
This FundNippon India Taiwan Equity Fund Growth3519.5 CR2.42
Fund Name1Y3Y
This FundAxis India Manufacturing Fund Growth17.25890
This FundKotak Active Momentum Fund Growth00
This FundBajaj Finserv Healthcare Fund Growth4.37830
This FundICICI Prudential PSU Equity Fund Growth11.9457106.1479
This FundNippon India Taiwan Equity Fund Growth230.8084247.25

FAQs

Bajaj Finserv Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Bajaj Finserv Healthcare Fund Growth is 2.39. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Bajaj Finserv Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -1.57%
  • 6 Months : -4.49%
  • 1 Year : 4.38%
  • 3 Years : 0.00%
Returns of Bajaj Finserv Healthcare Fund Growth are updated daily based on NAV of ₹ 9.323 as on Apr 09,2026. Since inception, the return has been 0.00%.

You can invest in Bajaj Finserv Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Bajaj Finserv Healthcare Fund Growth is ₹315 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Bajaj Finserv Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500